These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 31573335)
21. MUC5B: a good target for future therapy in pulmonary fibrosis? Mahida R; Turner AM Thorax; 2013 May; 68(5):401. PubMed ID: 23329274 [No Abstract] [Full Text] [Related]
22. XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia. Chen G; Ribeiro CMP; Sun L; Okuda K; Kato T; Gilmore RC; Martino MB; Dang H; Abzhanova A; Lin JM; Hull-Ryde EA; Volmer AS; Randell SH; Livraghi-Butrico A; Deng Y; Scherer PE; Stripp BR; O'Neal WK; Boucher RC Am J Respir Crit Care Med; 2019 Jul; 200(2):220-234. PubMed ID: 30973754 [No Abstract] [Full Text] [Related]
23. A common MUC5B promoter polymorphism and pulmonary fibrosis. Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741 [TBL] [Abstract][Full Text] [Related]
24. What is top of the charts? BPIFB1/LPLUNC1 localises to the bronchiolised epithelium in the honeycomb cysts in UIP. Bingle CD; Araujo B; Wallace WA; Hirani N; Bingle L Thorax; 2013 Dec; 68(12):1167-8. PubMed ID: 24014631 [No Abstract] [Full Text] [Related]
25. The Platenburg MGJP; Wiertz IA; van der Vis JJ; Crestani B; Borie R; Dieude P; Kannengiesser C; Burgers JA; Grutters JC; van Moorsel CHM Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 31949121 [No Abstract] [Full Text] [Related]
26. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment. Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872 [TBL] [Abstract][Full Text] [Related]
27. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice. Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287 [TBL] [Abstract][Full Text] [Related]
28. Bleomycin revisited: towards a more representative model of IPF? Scotton CJ; Chambers RC Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L439-41. PubMed ID: 20675435 [No Abstract] [Full Text] [Related]
29. MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis. Dhooria S; Bal A; Sehgal IS; Prasad KT; Kashyap D; Sharma R; Muthu V; Agarwal R; Aggarwal AN Chest; 2022 Oct; 162(4):824-827. PubMed ID: 35405109 [No Abstract] [Full Text] [Related]
30. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis. Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827 [TBL] [Abstract][Full Text] [Related]
31. [Current progression in the biomarkers of idiopathic pulmonary fibrosis]. Wang XF; Zhang YW; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):841-3. PubMed ID: 24507397 [No Abstract] [Full Text] [Related]
32. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605 [TBL] [Abstract][Full Text] [Related]